1-anilino-8-naphthalenesulfonate has been researched along with Dyslipidemia in 41 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rats were exposed to 1 or 10 μg/mL bisphenol A (BPA) in water during pregnancy and lactation." | 3.83 | Effect of Perinatal Bisphenol A Exposure on Serum Lipids and Lipid Enzymes in Offspring Rats of Different Sex. ( Gao, L; Jia, LH; Jia, Y; Peng, FY; Wang, HN; Wei, W; Zhang, L, 2016) |
| "Epidemiological studies indicate that NAFLD raises risk of fatal or non-fatal CVD events." | 2.72 | Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches. ( Corsini, A; Dongiovanni, P; Paolini, E; Ruscica, M; Sirtori, CR, 2021) |
| "Nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome (MS) are highly prevalent, affecting approximately one-third of the US population." | 2.58 | Nonalcoholic Fatty Liver Disease and Metabolic Syndrome. ( Kim, D; Kim, WR; Touros, A, 2018) |
| "Nephrotic syndrome is a highly prevalent disease that is associated with high morbidity despite notable advances in its treatment." | 2.58 | Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. ( Agrawal, S; Fornoni, A; Smoyer, WE; Zaritsky, JJ, 2018) |
| "Obesity is a disease that develops as a result of long-term positive energy balance." | 2.50 | [The role of gut microbiota in the pathogenesis of obesity]. ( Chudek, J; Kocełak, P; Olszanecka-Glinianowicz, M; Zak-Gołąb, A, 2014) |
| "Tangeretin treatment of hepatic cells also reduced the levels of both intracellular and secreted ANGPTL3 proteins." | 1.62 | The Lipid-Modulating Effect of Tangeretin on the Inhibition of Angiopoietin-like 3 (ANGPTL3) Gene Expression through Regulation of LXRα Activation in Hepatic Cells. ( Chao, TY; Chen, PY; Gao, WY; Hsu, HJ; Lin, CY; Wang, CY; Wu, MJ; Yen, JH, 2021) |
| "The association between nonalcoholic fatty liver disease (NAFLD) and apolipoprotein C3 gene (APOC3) promoter region single-nucleotide polymorphisms (SNPs) rs2854117 and rs2854116 is controversial." | 1.43 | APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases. ( Chen, GY; Fan, JG; Mi, YQ; Pan, Q; Shen, F; Zhang, RN; Zheng, RD; Zhou, D; Zhu, CY, 2016) |
| " Chronic administration of REGN1500 to dyslipidemic C57Bl/6 mice for 8 weeks reduced circulating plasma levels of TG, LDL-cholesterol (LDL-C), and HDL-cholesterol (HDL-C) without any changes in liver, adipose, or heart TG contents." | 1.42 | ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys. ( Alexa, CA; Buckler, D; Cohen, JC; Gromada, J; Gusarova, V; Hobbs, HH; Kim, JH; Mintah, IJ; Murphy, AJ; Rafique, A; Shihanian, LM; Valenzuela, DM; Wang, Y; Xin, Y; Yancopoulos, GD, 2015) |
| "Genetic risk ratios for type 2 diabetes for a 0." | 1.42 | HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study. ( Frikke-Schmidt, R; Haase, CL; Nordestgaard, BG; Tybjærg-Hansen, A, 2015) |
| "Ezetimibe is a lipid-lowering agent that inhibits the intestinal absorption of cholesterol and other related phytosterols." | 1.34 | Ezetimibe-induced acute pancreatitis. ( Ahmad, I; Hotiana, M; Hussain, M; Rahman, F; Ruby, E; Usman, H, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (24.39) | 29.6817 |
| 2010's | 28 (68.29) | 24.3611 |
| 2020's | 3 (7.32) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, PY | 1 |
| Chao, TY | 1 |
| Hsu, HJ | 1 |
| Wang, CY | 1 |
| Lin, CY | 1 |
| Gao, WY | 1 |
| Wu, MJ | 1 |
| Yen, JH | 1 |
| Fukaishi, T | 1 |
| Minami, I | 1 |
| Masuda, S | 1 |
| Miyachi, Y | 1 |
| Tsujimoto, K | 1 |
| Izumiyama, H | 1 |
| Hashimoto, K | 1 |
| Yoshida, M | 1 |
| Takahashi, S | 1 |
| Kashimada, K | 1 |
| Morio, T | 1 |
| Kosaki, K | 1 |
| Maezawa, Y | 1 |
| Yokote, K | 1 |
| Yoshimoto, T | 1 |
| Yamada, T | 1 |
| Dongiovanni, P | 1 |
| Paolini, E | 1 |
| Corsini, A | 1 |
| Sirtori, CR | 1 |
| Ruscica, M | 1 |
| Kim, D | 1 |
| Touros, A | 1 |
| Kim, WR | 1 |
| Agrawal, S | 1 |
| Zaritsky, JJ | 1 |
| Fornoni, A | 1 |
| Smoyer, WE | 1 |
| Yang, S | 1 |
| Yin, RX | 1 |
| Miao, L | 1 |
| Zhou, YG | 1 |
| Wu, J | 1 |
| Zhang, QH | 1 |
| Kratky, D | 1 |
| Obrowsky, S | 1 |
| Kolb, D | 1 |
| Radovic, B | 1 |
| Elshourbagy, NA | 1 |
| Meyers, HV | 1 |
| Abdel-Meguid, SS | 1 |
| Zak-Gołąb, A | 1 |
| Olszanecka-Glinianowicz, M | 1 |
| Kocełak, P | 1 |
| Chudek, J | 1 |
| Lange, LA | 1 |
| Hu, Y | 1 |
| Zhang, H | 1 |
| Xue, C | 1 |
| Schmidt, EM | 1 |
| Tang, ZZ | 1 |
| Bizon, C | 1 |
| Lange, EM | 1 |
| Smith, JD | 1 |
| Turner, EH | 1 |
| Jun, G | 1 |
| Kang, HM | 1 |
| Peloso, G | 1 |
| Auer, P | 1 |
| Li, KP | 1 |
| Flannick, J | 1 |
| Zhang, J | 1 |
| Fuchsberger, C | 1 |
| Gaulton, K | 1 |
| Lindgren, C | 1 |
| Locke, A | 1 |
| Manning, A | 1 |
| Sim, X | 1 |
| Rivas, MA | 1 |
| Holmen, OL | 1 |
| Gottesman, O | 1 |
| Lu, Y | 1 |
| Ruderfer, D | 1 |
| Stahl, EA | 1 |
| Duan, Q | 1 |
| Li, Y | 1 |
| Durda, P | 1 |
| Jiao, S | 1 |
| Isaacs, A | 1 |
| Hofman, A | 1 |
| Bis, JC | 1 |
| Correa, A | 1 |
| Griswold, ME | 1 |
| Jakobsdottir, J | 1 |
| Smith, AV | 1 |
| Schreiner, PJ | 1 |
| Feitosa, MF | 2 |
| Zhang, Q | 1 |
| Huffman, JE | 1 |
| Crosby, J | 1 |
| Wassel, CL | 1 |
| Do, R | 1 |
| Franceschini, N | 1 |
| Martin, LW | 1 |
| Robinson, JG | 1 |
| Assimes, TL | 1 |
| Crosslin, DR | 1 |
| Rosenthal, EA | 1 |
| Tsai, M | 1 |
| Rieder, MJ | 1 |
| Farlow, DN | 1 |
| Folsom, AR | 1 |
| Lumley, T | 1 |
| Fox, ER | 1 |
| Carlson, CS | 1 |
| Peters, U | 1 |
| Jackson, RD | 1 |
| van Duijn, CM | 1 |
| Uitterlinden, AG | 1 |
| Levy, D | 1 |
| Rotter, JI | 1 |
| Taylor, HA | 1 |
| Gudnason, V | 1 |
| Siscovick, DS | 1 |
| Fornage, M | 1 |
| Borecki, IB | 2 |
| Hayward, C | 1 |
| Rudan, I | 1 |
| Chen, YE | 1 |
| Bottinger, EP | 1 |
| Loos, RJ | 1 |
| Sætrom, P | 1 |
| Hveem, K | 1 |
| Boehnke, M | 1 |
| Groop, L | 1 |
| McCarthy, M | 1 |
| Meitinger, T | 1 |
| Ballantyne, CM | 1 |
| Gabriel, SB | 1 |
| O'Donnell, CJ | 1 |
| Post, WS | 1 |
| North, KE | 1 |
| Reiner, AP | 1 |
| Boerwinkle, E | 1 |
| Psaty, BM | 1 |
| Altshuler, D | 1 |
| Kathiresan, S | 1 |
| Lin, DY | 1 |
| Jarvik, GP | 1 |
| Cupples, LA | 1 |
| Kooperberg, C | 1 |
| Wilson, JG | 1 |
| Nickerson, DA | 1 |
| Abecasis, GR | 1 |
| Rich, SS | 1 |
| Tracy, RP | 1 |
| Willer, CJ | 1 |
| Ferrer, R | 1 |
| Pardina, E | 1 |
| Rossell, J | 1 |
| Baena-Fustegueras, JA | 1 |
| Lecube, A | 1 |
| Balibrea, JM | 1 |
| Caubet, E | 1 |
| González, O | 1 |
| Vilallonga, R | 1 |
| Fort, JM | 1 |
| Peinado-Onsurbe, J | 1 |
| Gusarova, V | 1 |
| Alexa, CA | 1 |
| Wang, Y | 1 |
| Rafique, A | 1 |
| Kim, JH | 1 |
| Buckler, D | 1 |
| Mintah, IJ | 1 |
| Shihanian, LM | 1 |
| Cohen, JC | 1 |
| Hobbs, HH | 1 |
| Xin, Y | 1 |
| Valenzuela, DM | 1 |
| Murphy, AJ | 1 |
| Yancopoulos, GD | 1 |
| Gromada, J | 1 |
| Haase, CL | 1 |
| Tybjærg-Hansen, A | 1 |
| Nordestgaard, BG | 1 |
| Frikke-Schmidt, R | 1 |
| Guardiola, M | 1 |
| Echeverria, P | 1 |
| González, M | 1 |
| Vallvé, JC | 1 |
| Puig, J | 1 |
| Clotet, B | 1 |
| Ribalta, J | 1 |
| Negredo, E | 1 |
| Andrés-Blasco, I | 1 |
| Herrero-Cervera, A | 1 |
| Vinué, Á | 1 |
| Martínez-Hervás, S | 1 |
| Piqueras, L | 1 |
| Sanz, MJ | 1 |
| Burks, DJ | 1 |
| González-Navarro, H | 1 |
| Winter, MP | 1 |
| Wiesbauer, F | 1 |
| Alimohammadi, A | 1 |
| Blessberger, H | 1 |
| Pavo, N | 1 |
| Schillinger, M | 1 |
| Huber, K | 1 |
| Wojta, J | 1 |
| Lang, IM | 1 |
| Maurer, G | 1 |
| Goliasch, G | 1 |
| Zhang, RN | 1 |
| Zheng, RD | 1 |
| Mi, YQ | 1 |
| Zhou, D | 1 |
| Shen, F | 1 |
| Chen, GY | 1 |
| Zhu, CY | 1 |
| Pan, Q | 1 |
| Fan, JG | 1 |
| Vaziri, ND | 1 |
| Christiansen, MK | 1 |
| Jensen, JM | 1 |
| Brøndberg, AK | 1 |
| Bøtker, HE | 1 |
| Jensen, HK | 1 |
| Gao, L | 1 |
| Wang, HN | 1 |
| Zhang, L | 1 |
| Peng, FY | 1 |
| Jia, Y | 1 |
| Wei, W | 1 |
| Jia, LH | 1 |
| Myers, RH | 1 |
| Pankow, JS | 1 |
| Province, MA | 1 |
| Mekki, K | 1 |
| Prost, J | 1 |
| Remaoun, M | 1 |
| Belleville, J | 1 |
| Bouchenak, M | 1 |
| Conklin, DJ | 1 |
| Barski, OA | 1 |
| Lesgards, JF | 1 |
| Juvan, P | 1 |
| Rezen, T | 1 |
| Rozman, D | 1 |
| Prough, RA | 1 |
| Vladykovskaya, E | 1 |
| Liu, S | 1 |
| Srivastava, S | 1 |
| Bhatnagar, A | 1 |
| Kashani Farid, MA | 1 |
| Azizi, F | 1 |
| Hedayati, M | 1 |
| Daneshpour, MS | 1 |
| Shamshiri, AR | 1 |
| Siassi, F | 1 |
| Johnston, TP | 1 |
| Zhang, Y | 1 |
| Klein, K | 1 |
| Sugathan, A | 1 |
| Nassery, N | 1 |
| Dombkowski, A | 1 |
| Zanger, UM | 1 |
| Waxman, DJ | 1 |
| Mangravite, LM | 1 |
| Chiu, S | 1 |
| Wojnoonski, K | 1 |
| Rawlings, RS | 1 |
| Bergeron, N | 1 |
| Krauss, RM | 1 |
| Wild, RA | 1 |
| Vaidya, H | 1 |
| Prajapati, A | 1 |
| Rajani, M | 1 |
| Sudarsanam, V | 1 |
| Padh, H | 1 |
| Goyal, RK | 1 |
| Bie, J | 1 |
| Zhao, B | 2 |
| Marqueen, KE | 1 |
| Wang, J | 1 |
| Szomju, B | 1 |
| Ghosh, S | 1 |
| Ampuero, J | 1 |
| Romero-Gómez, M | 1 |
| Foulkes, AS | 2 |
| DeGruttola, VG | 1 |
| Nonyane, BA | 1 |
| Krarup, NT | 1 |
| Grarup, N | 1 |
| Banasik, K | 1 |
| Friedrichsen, M | 1 |
| Færch, K | 1 |
| Sandholt, CH | 1 |
| Jørgensen, T | 1 |
| Poulsen, P | 1 |
| Witte, DR | 1 |
| Vaag, A | 1 |
| Sørensen, T | 1 |
| Pedersen, O | 1 |
| Hansen, T | 1 |
| Lian, J | 1 |
| Quiroga, AD | 1 |
| Li, L | 1 |
| Lehner, R | 1 |
| De Vries, R | 1 |
| Wolffenbuttel, BH | 1 |
| Sluiter, WJ | 1 |
| van Tol, A | 1 |
| Dullaart, RP | 1 |
| Nelson, RH | 1 |
| Miles, JM | 1 |
| Stancáková, A | 1 |
| Baldaufová, L | 1 |
| Javorský, M | 1 |
| Kozárová, M | 1 |
| Salagovic, J | 1 |
| Tkác, I | 1 |
| Ahmad, I | 1 |
| Ruby, E | 1 |
| Usman, H | 1 |
| Hotiana, M | 1 |
| Hussain, M | 1 |
| Rahman, F | 1 |
| Chhabria, MT | 1 |
| Suhagia, BN | 1 |
| Brahmkshatriya, PS | 1 |
| Sheng, L | 1 |
| Qian, Z | 1 |
| Shi, Y | 1 |
| Yang, L | 1 |
| Xi, L | 1 |
| Xu, X | 1 |
| Ji, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina[NCT03696940] | Phase 3 | 120 participants (Actual) | Interventional | 2018-05-28 | Active, not recruiting | ||
| Lipoprotein Effects of Substituting Beef Protein for Carbohydrate[NCT00852267] | 67 participants (Actual) | Interventional | 2008-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for 1-anilino-8-naphthalenesulfonate and Dyslipidemia
| Article | Year |
|---|---|
Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches.
Topics: Acyltransferases; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dysli | 2021 |
Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.
Topics: Dyslipidemias; Humans; Hyperglycemia; Hypertension; Lipase; Membrane Proteins; Metabolic Syndrome; N | 2018 |
Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.
Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, VLDL; Dyslipidemias; Ezetimibe | 2018 |
Pleiotropic regulation of mitochondrial function by adipose triglyceride lipase-mediated lipolysis.
Topics: Adipose Tissue; Animals; Dyslipidemias; Humans; Lipase; Lipolysis; Liver; Macrophages; Mitochondria; | 2014 |
Cholesterol: the good, the bad, and the ugly - therapeutic targets for the treatment of dyslipidemia.
Topics: Animals; Apolipoprotein A-I; Apolipoproteins B; Atherosclerosis; Cardiovascular Diseases; Cholestero | 2014 |
[The role of gut microbiota in the pathogenesis of obesity].
Topics: Angiopoietin-Like Protein 4; Angiopoietins; Animals; Diabetes Mellitus, Type 2; Diet; Disease Models | 2014 |
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
Topics: Cholesterol; Creatinine; Dyslipidemias; Humans; Lipase; Lipoproteins; Liver; Nephrotic Syndrome; Pro | 2016 |
Dyslipidemia in PCOS.
Topics: Androgens; Animals; Apolipoproteins; Dyslipidemias; Female; Humans; Lipase; Lipoproteins, LDL; Polyc | 2012 |
[Influence of non-alcoholic fatty liver disease on cardiovascular disease].
Topics: Apolipoprotein C-III; Atherosclerosis; Cardiovascular Diseases; Carotid Intima-Media Thickness; Chol | 2012 |
The PNPLA3 rs738409 G-allele associates with reduced fasting serum triglyceride and serum cholesterol in Danes with impaired glucose regulation.
Topics: Body Mass Index; Case-Control Studies; Cholesterol; Denmark; Dyslipidemias; Fasting; Female; Gene Fr | 2012 |
The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes.
Topics: Anti-Obesity Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Dysli | 2005 |
HDL elevation and lipid lowering therapy: current scenario and future perspectives.
Topics: Animals; Apolipoprotein A-I; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; | 2007 |
3 trials available for 1-anilino-8-naphthalenesulfonate and Dyslipidemia
| Article | Year |
|---|---|
LIPG SNPs, their haplotypes and gene-environment interactions on serum lipid levels.
Topics: Adult; Aged; Aged, 80 and over; Apolipoprotein A-I; Apolipoprotein B-100; China; Cholesterol, HDL; C | 2019 |
Decreased lipases and fatty acid and glycerol transporter could explain reduced fat in diabetic morbidly obese.
Topics: Adiposity; Adult; Aquaporins; Biological Transport; CD36 Antigens; Diabetes Mellitus, Type 2; Down-R | 2014 |
Changes in atherogenic dyslipidemia induced by carbohydrate restriction in men are dependent on dietary protein source.
Topics: Adolescent; Animals; Apolipoproteins B; Cattle; Cholesterol, LDL; Cross-Over Studies; Diet, Atheroge | 2011 |
26 other studies available for 1-anilino-8-naphthalenesulfonate and Dyslipidemia
| Article | Year |
|---|---|
The Lipid-Modulating Effect of Tangeretin on the Inhibition of Angiopoietin-like 3 (ANGPTL3) Gene Expression through Regulation of LXRα Activation in Hepatic Cells.
Topics: Angiopoietin-Like Protein 3; Angiopoietin-like Proteins; Drug Evaluation, Preclinical; Dyslipidemias | 2021 |
A case of generalized lipodystrophy-associated progeroid syndrome treated by leptin replacement with short and long-term monitoring of the metabolic and endocrine profiles.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; Diabetes Mellitus; Dyslipid | 2020 |
Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol.
Topics: Adult; Aged; Apolipoproteins E; Cholesterol, LDL; Cohort Studies; Dyslipidemias; Exome; Female; Foll | 2014 |
ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys.
Topics: Angiopoietin-Like Protein 3; Angiopoietin-like Proteins; Angiopoietins; Animals; Antibodies, Monoclo | 2015 |
HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study.
Topics: Apolipoprotein A-I; ATP Binding Cassette Transporter 1; Cholesterol Ester Transfer Proteins; Cholest | 2015 |
Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner.
Topics: Alleles; Antiretroviral Therapy, Highly Active; Atherosclerosis; Cholesterol Ester Transfer Proteins | 2015 |
Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis.
Topics: Animals; Blood Glucose; Chemokine CCL2; Diet, High-Fat; Dyslipidemias; Glucose Intolerance; Inflamma | 2015 |
Soluble galectin-3 is associated with premature myocardial infarction.
Topics: Adult; Biomarkers; Blood Proteins; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, | 2016 |
APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.
Topics: Adult; Alanine Transaminase; Apolipoprotein C-III; Asian People; Body Mass Index; Case-Control Studi | 2016 |
Cardiovascular risk factor control is insufficient in young patients with coronary artery disease.
Topics: Adult; Age of Onset; Antihypertensive Agents; Biomarkers; Blood Pressure; Body Mass Index; Cholester | 2016 |
Effect of Perinatal Bisphenol A Exposure on Serum Lipids and Lipid Enzymes in Offspring Rats of Different Sex.
Topics: Adiponectin; Adipose Tissue; Animals; Benzhydryl Compounds; Body Weight; Dyslipidemias; Female; Huma | 2016 |
LIPC variants in the promoter and intron 1 modify HDL-C levels in a sex-specific fashion.
Topics: Adult; Aged; Cholesterol, HDL; Dyslipidemias; Female; Gene Frequency; Haplotypes; Humans; Introns; L | 2009 |
Long term hemodialysis aggravates lipolytic activity reduction and very low density, low density lipoproteins composition in chronic renal failure patients.
Topics: Adult; Apolipoprotein C-II; Apolipoprotein C-III; Atherosclerosis; Biomarkers; Cholesterol; Dyslipid | 2009 |
Acrolein consumption induces systemic dyslipidemia and lipoprotein modification.
Topics: Acrolein; Animals; Apolipoproteins E; Dose-Response Relationship, Drug; Drug Administration Routes; | 2010 |
Association between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: a cross sectional study.
Topics: Adult; Aged; Aged, 80 and over; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cohort Studie | 2010 |
Poloxamer 407 as a general lipase inhibitor: its implications in lipid metabolism and atheroma formation in C57BL/6 mice.
Topics: Animals; Atherosclerosis; Dyslipidemias; Humans; Intercellular Adhesion Molecule-1; Lipase; Lipid Me | 2010 |
Transcriptional profiling of human liver identifies sex-biased genes associated with polygenic dyslipidemia and coronary artery disease.
Topics: Adult; Aged; Animals; Apolipoprotein A-V; Apolipoproteins A; ATP Binding Cassette Transporter 1; ATP | 2011 |
Beneficial effects of swertiamarin on dyslipidaemia in streptozotocin-induced type 2 diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dyslipidemias; G | 2012 |
Macrophage-specific transgenic expression of cholesteryl ester hydrolase attenuates hepatic lipid accumulation and also improves glucose tolerance in ob/ob mice.
Topics: Animals; Basal Metabolism; Dyslipidemias; Glucose Intolerance; Hepatitis; Insulin Resistance; Kupffe | 2012 |
A resampling-based approach to multiple testing with uncertainty in phase.
Topics: Algorithms; Antiretroviral Therapy, Highly Active; Cholesterol, HDL; Computer Simulation; Dyslipidem | 2007 |
Multiple imputation and random forests (MIRF) for unobservable, high-dimensional data.
Topics: Anti-HIV Agents; Apolipoproteins; Cohort Studies; Computer Simulation; Data Interpretation, Statisti | 2007 |
Ces3/TGH deficiency improves dyslipidemia and reduces atherosclerosis in Ldlr(-/-) mice.
Topics: Animals; Aorta; Apolipoproteins B; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, V | 2012 |
Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.
Topics: Case-Control Studies; Cholesterol, HDL; Diabetes Mellitus, Type 2; Dyslipidemias; Heparin; Humans; L | 2005 |
Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome.
Topics: Aged; Apolipoprotein C-III; Apolipoproteins B; Cholesterol; Cholesterol Ester Transfer Proteins; Cho | 2006 |
Ezetimibe-induced acute pancreatitis.
Topics: Anticholesteremic Agents; Azetidines; Diagnosis, Differential; Dyslipidemias; Ezetimibe; Female; Fol | 2007 |
Crocetin improves the insulin resistance induced by high-fat diet in rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Carnitine O-Palmitoyltransferase; Carotenoids; Dietary Fats; | 2008 |